DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Simon T, Hero B, Faldum A. et al.
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy.
BMC Cancer 2011;
11: 21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.